These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7714795)

  • 41. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey.
    Katz JL; Witkin JM
    Psychopharmacology (Berl); 1993; 113(1):19-25. PubMed ID: 7862823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of dopamine D1 receptor full agonists in rats trained to discriminate SKF 38393.
    Gleason SD; Witkin JM
    Behav Pharmacol; 2004 Feb; 15(1):85-9. PubMed ID: 15075630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
    Bergman J; Warren PH
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1102-8. PubMed ID: 2539457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
    Simon P; Charpentier S; Costentin J
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    Winkler JD; Weiss B
    J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Functional interplay of dopamine D1 and D2 receptors in the immune response control in different psychoemotional states].
    Al'perina EL; Gevorgian MM
    Eksp Klin Farmakol; 2010 Jun; 73(6):2-4. PubMed ID: 20726342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys.
    Schindler CW; Gilman JP; Bergman J; Mello NK; Woosley RL; Goldberg SR
    J Pharmacol Exp Ther; 2002 Jan; 300(1):180-7. PubMed ID: 11752114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions.
    Caine SB; Negus SS; Mello NK
    Psychopharmacology (Berl); 2000 Jan; 148(1):41-51. PubMed ID: 10663416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    Akai T; Ozawa M; Yamaguchi M; Mizuta E; Kuno S
    J Pharmacol Exp Ther; 1995 Apr; 273(1):309-14. PubMed ID: 7714782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K; Smith SE; Sharp T
    J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists.
    Desai RI; Terry P; Katz JL
    Behav Pharmacol; 2003 May; 14(3):223-8. PubMed ID: 12799524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opposing effects on the phrenic motor pathway attributed to dopamine-D1 and -D3/D2 receptor activation.
    Lalley PM; Mifflin SW
    Respir Physiol Neurobiol; 2012 Apr; 181(2):183-93. PubMed ID: 22465544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats.
    Frederick DL; Allen JD
    Pharmacol Biochem Behav; 1996 Apr; 53(4):759-64. PubMed ID: 8801575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists.
    Kantak KM; Edwards MA; Spealman RD
    J Pharmacol Exp Ther; 1995 Aug; 274(2):657-65. PubMed ID: 7636725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys.
    Katz JL; Witkin JM
    Psychopharmacology (Berl); 1992; 109(1-2):241-4. PubMed ID: 1365665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.
    Gnanalingham KK; Erol DD; Hunter AJ; Smith LA; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(3):275-86. PubMed ID: 7770603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.